Skip to main content
. 2020 Feb 5;156(3):258–269. doi: 10.1001/jamadermatol.2019.4029

Figure 2. Evidence Network for Network Meta-analysis (NMA) of Short-term Psoriasis Area and Severity Index (PASI) (Base Case).

Figure 2.

The reference citations for the NMA are as follows: PSOR-010/LIBERATE: reference 20; CIMPASI-1: reference 65; CIMPASI-2: reference 65; CIMPACT: reference 66; reSURFACE-1: reference 68; Papp 2005: reference 38; reSURFACE-2: reference 68; PSOR-008/ESTEEM-1: reference 71; PSOR-009/ESTEEM-2: reference 72; PSOR-005: reference 73; Ohtsuki 2017: reference 74; NCT00245765: reference 67; Papp 2015: reference 69; Leonardi 2003: reference 37; van de Kerkhof 2008: reference 39; Gottlieb 2003: reference 40; EXPRESS: reference 41; EXPRESS II: reference 42; SPIRIT: reference 43; Chaudhari 2001: reference 44; Torii 2010: reference 45; Yang 2012: reference 46; BRIDGE: reference 31; VOYAGE-1: reference 17; VOYAGE-2: reference 18; ORION: reference 60; Ohtsuki 2018: reference 61; LOTUS: reference 54; PEARL: reference 55; PHOENIX 1: reference 56; PHOENIX 2: reference 57; Igarashi 2012: reference 58; Asahina 2010: reference 30; Bissonnette 2013: reference 31; REVEAL: reference 32; CHAMPION: reference 33; Gordon 2006: reference 34; Cai 2017: reference 35; X-PLORE: reference 58; ACCEPT: reference 53; Nakagawa 2016: reference 62; Papp 2012: reference 63; AMAGINE-1: reference 64; AMAGINE-2: reference 19; AMAGINE-3: reference 19; ERASURE: reference 50; FEATURE: reference 51; FIXTURE: reference 50; JUNCTURE: reference 52; UltIMMa-1: reference 15; UltIMMa-2: reference 15; IMMhance: reference 83; UNCOVER 1: reference 47; UNCOVER 2: reference 48; UNCOVER 3: reference 48; VIP-U: reference 59; IMMvent: reference 21; CLEAR: reference 13; CLARITY: reference 26; and IXORA-S: reference 16.